The initial public offer of Kerrisdale Capital Management raised about $100 million from investors according to Reuters. Kerrisdale intends to use the money rationally in stock a certain public company in the infancy stages. This a unique approach considering companies have been in the past channeling such investments in mortgage backed up securities or in a receding company for recovery.
SahmAdrangi, the founder, and Chief Investor was also pleased with how Kerrisdale raise the figure within no time as expressed in a mail he recently sent out to other investors. Kerrisdale analysts, Adrangi and Shane Wilson are seeking alluring antics to raise more for the same course through the development of a company website and video among others.
It is allegedly reported that the company underway will be launched soon enough. With the $500 million Kerrisdale is already operating with, this should be a good bargain. Its analyst makes calculated risk in the hedge fund and has been able to take home an annual return of 28% averagely.
He is a business person residing in the Greater New York City. He is the founder and Chief Investment officer of Kerrisdale Capital Management Limited Liability Company, although he practically has work in all its divisions. Adrangi was a Yale University graduate in Economics in 2003. The subsequent year came with an opportunity to work at the Deutsche Bank in leveraging finance groups.
In 2005, a boutique investment bank, Chanin Capital Partners sourced for his services in revolutionary bankruptcy restructuring. His impact in restoring stability in the two branches at Los Angeles and New York saw Longacre Fund Management LLC give him an offer. At the time Longacre Fund had a distressed debt of $2 billion, and SahmAdrangi was able to reverse to favorable terms in his tenure of two years ending 2009.
Adrangi founded an investment firm, Kerrisdale Capital Management in 2009 and had been working through that platform to date. His other past achievements include reinstating some collapsing Chinese companies which now trade in the Securities and Exchange Commission. SahmAdrangi has partnered with Globalstar company, Zafgen and Sage Therapeutics.